Utility of levetiracetam in patients with subarachnoid hemorrhage
- PMID: 19864168
- DOI: 10.1016/j.seizure.2009.09.003
Utility of levetiracetam in patients with subarachnoid hemorrhage
Abstract
Purpose: To determine the utility and tolerability of levetiracetam (LEV) compared to phenytoin (PHT) in preventing clinical seizures in patients with subarachnoid hemorrhage (SAH).
Methods: Utility and tolerability of PHT and LEV in patients with SAH were determined by the occurrence of breakthrough clinical seizures or adverse events necessitating a change of medication. Comparisons were performed with Chi-square tests.
Results: All 176 patients were initially treated with PHT. No breakthrough clinical seizures occurred. In 70 (39.8%) patients, PHT was replaced with LEV due to adverse events including elevation of transaminases, thrombocytopenia, unexplained fever, rash, gastrointestinal disturbance, and worsening mental status. After switching to LEV, all adverse effects resolved except gastrointestinal disturbance and worsening mental status in 4 patients. Adverse events occurred more often in patients taking PHT.
Conclusions: In patients with SAH, LEV appears to have superior tolerability compared to PHT.
Similar articles
-
Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery.Neurology. 2008 Aug 26;71(9):665-9. doi: 10.1212/01.wnl.0000324624.52935.46. Neurology. 2008. PMID: 18725591
-
Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage.World Neurosurg. 2011 Feb;75(2):269-74. doi: 10.1016/j.wneu.2010.09.002. World Neurosurg. 2011. PMID: 21492729
-
Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.Neurocrit Care. 2010 Apr;12(2):165-72. doi: 10.1007/s12028-009-9304-y. Neurocrit Care. 2010. PMID: 19898966 Clinical Trial.
-
Early and Late Posttraumatic Epilepsy in the Setting of Traumatic Brain Injury: A Meta-analysis and Review of Antiepileptic Management.World Neurosurg. 2018 Feb;110:e901-e906. doi: 10.1016/j.wneu.2017.11.116. Epub 2017 Dec 2. World Neurosurg. 2018. PMID: 29196247 Review.
-
Antiepileptic drugs in aneurysmal subarachnoid hemorrhage.Rev Neurol Dis. 2008 Fall;5(4):178-81. Rev Neurol Dis. 2008. PMID: 19122570 Review.
Cited by
-
Prophylactic Antiepileptics and Seizure Incidence Following Subarachnoid Hemorrhage: A Propensity Score-Matched Analysis.Stroke. 2016 Jul;47(7):1754-60. doi: 10.1161/STROKEAHA.116.013766. Epub 2016 Jun 14. Stroke. 2016. PMID: 27301932 Free PMC article.
-
Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.CNS Drugs. 2016 Aug;30(8):677-88. doi: 10.1007/s40263-016-0365-0. CNS Drugs. 2016. PMID: 27395404 Review.
-
Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage.Neurocrit Care. 2011 Sep;15(2):247-56. doi: 10.1007/s12028-011-9584-x. Neurocrit Care. 2011. PMID: 21751102 Review.
-
Levetiracetam use in the critical care setting.Front Neurol. 2013 Aug 23;4:121. doi: 10.3389/fneur.2013.00121. eCollection 2013. Front Neurol. 2013. PMID: 23986742 Free PMC article.
-
A Randomized Trial of Brief Versus Extended Seizure Prophylaxis After Aneurysmal Subarachnoid Hemorrhage.Neurocrit Care. 2018 Apr;28(2):169-174. doi: 10.1007/s12028-017-0440-5. Neurocrit Care. 2018. PMID: 28831717 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical